new glp 1 gip GLP-1 vs. GLP-1 + GIP: What's the Difference for your Metabolism? Compounded GLP-1 / GIP
Description
In animal models, GLP-1 agonists have been shown to significantly delay the onset and severity of experimental autoimmune encephalopathy symptoms, as well as to increase nerve myelination and brain weight
Raben A, Mygind E, Saltin B, Astrup A
This episode is more than just a product setback
Delayed gastric emptying, gastroparesis-like symptoms, intestinal obstruction, biliary disease, and pancreatic safety concerns were variably reported, with heterogeneous and sometimes conflicting evidence across studies
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes
